Content about Specialty Pharmacy

October 25, 2009
Third patient taking arthritis drug develops PML

A third case of a deadly brain infection has occurred in a patient using a...

October 22, 2009
Bayer, Onyx to enroll patients for thyroid cancer clinical trial

German drug maker Bayer HealthCare and partner Onyx Pharmaceuticals have started enrolling patients for a...

October 22, 2009
The Apothecary Shops appoints execs

A specialty pharmacy company that has lately expanded on a regional level now plans to...

October 21, 2009
FDA approves drug for managing plasma uric acid levels

The Food and Drug Administration has approved a new drug for managing levels of a...

October 19, 2009
Calif. health plan selects Diplomat as exclusive specialty Rx provider

The Inland Empire Health Plan in California has selected Diplomat Specialty Pharmacy to be its...

October 15, 2009
FDA approves GSK's HPV vaccine

Merck & Co.’s highly successful human papillomavirus vaccine Gardasil has a new competitor....

October 14, 2009
FDA advisory committee supports efficacy, safety data of Acorda's MS drug

A Food and Drug Administration advisory committee has given a favorable review to an investigational...

October 14, 2009
Sanofi Pasteur: Only one dose of H1N1 vaccine needed for children under 9 years old

Sanofi Pasteur, the vaccines division of the Sanofi-Aventis Group, on Wednesday announced that clinical trials...

October 13, 2009
Questions raised about promising HIV vaccine trial results

The excitement over data from a late-stage clinical trial of an HIV vaccine regimen may...

October 13, 2009
Trading halted on Acorda as FDA considers new MS drug

It’s been bad news lately for Acorda Therapeutics....

October 12, 2009
FDA approves hereditary angioedema treatment

The Food and Drug Administration has approved a drug designed to treat symptoms associated with...

October 12, 2009
Novartis enters agreement for U.S., Canadian rights for schizophrenia treatment

A drug maker has entered an exclusive agreement to launch an oral therapy for the...

October 8, 2009
FDA rejects colorectal cancer treatment

The Food and Drug Administration has rejected the approval application for a drug to treat...

October 8, 2009
Late-stage clinical trial results: MS drug is effective

Patients taking an investigational drug for multiple sclerosis fared better than those taking placebo, according...

October 7, 2009
BDSI to launch pain treatment associated with cancer

A new treatment for treating breakthrough pain associated with cancer will hit the market next...

October 7, 2009
FDA advisory committee approves Pfizer's HIV treatment

A Food and Drug Administration advisory committee has recommended approval for an HIV drug as...

October 7, 2009
Medco report: Specialty pharmacy spending driven by cancer drugs

Cancer drugs will become the biggest driver of specialty pharmacy spending, with global sales of...

October 7, 2009
Sanofi Pasteur: H1N1 shot boosts immune response

Sanofi Pasteur, the vaccines division of the Sanofi-Aventis Group, on Thursday announced that a single...

October 6, 2009
Sandoz launches first biosimilar

The generics arm of Swiss drug maker Novartis has launched Japan’s first biosimilar....

October 5, 2009
FDA approves 100th antiretroviral drug for PEPFAR

The Food and Drug Administration has approved the 100th antiretroviral drug under the President's Emergency...

October 5, 2009
FDA scientists consider HIV treatment safe as first-line treatment

A drug made by Pfizer for treating HIV is safe for patients who have not...

October 4, 2009
FDA tentatively approves Flomax generic

A specialty pharmaceutical company announced the tentative approval of its benign prostatic hyperplasia treatment....

October 4, 2009
Lucentis effective in treating RVO, studies find

Patients receiving an investigational drug for internal swelling of the eye due to blocked veins...

October 1, 2009
Amgen, GSK, Novartis win top drug industry award

Biotechnology company Amgen won a 2009 Prix Galien Award for a drug used to treat...

September 29, 2009
Clinical trial results conclude Novartis' MS drug yields 'significant' results

Patients taking an investigational drug for multiple sclerosis experienced “significant” reductions in relapses and disability...

© 2013 Drug Store News. All Rights Reserved.